Literature DB >> 29434381

ISMP Adverse Drug Reactions: Influenza Vaccine-Induced Stevens-Johnson Syndrome; Vilazodone-Induced Nightmares; Dabigatran-Induced Pustular Eruptions; Neurotoxic and Cardiotoxic Symptoms After Cannabis Concentrate Exposure; Rosuvastatin-Induced Skin Eruption.

Michael A Mancano1.   

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA) MedWatch program (800-FDA-1088). If you have reported an interesting, preventable ADR to MedWatch, please consider sharing the account with our readers. Write to Dr. Mancano at ISMP, 200 Lakeside Drive, Suite 200, Horsham, PA 19044 (phone: 215-707-4936; e-mail: mmancano@temple.edu). Your report will be published anonymously unless otherwise requested. This feature is provided by the Institute for Safe Medication Practices (ISMP) in cooperation with the FDA's MedWatch program and Temple University School of Pharmacy. ISMP is an FDA MedWatch partner.

Entities:  

Year:  2017        PMID: 29434381      PMCID: PMC5805017          DOI: 10.1177/0018578717739727

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  5 in total

1.  Stevens-Johnson Syndrome After Influenza Vaccine Injection.

Authors:  T Oda; Y Sawada; E Okada; T Yamaguchi; S Ohmori; S Haruyama; M Yoshioka; M Nakamura
Journal:  J Investig Allergol Clin Immunol       Date:  2017       Impact factor: 4.333

2.  Drug Eruption Caused by Rosuvastatin.

Authors:  T Oda; Y Sawada; T Yamaguchi; S Ohmori; S Haruyama; M Yoshioka; E Okada; M Nakamura
Journal:  J Investig Allergol Clin Immunol       Date:  2017       Impact factor: 4.333

3.  Palmoplantar pustular eruption due to dabigatran.

Authors:  Rachel Schleichert; Ronald Goldner; Timm Dickfeld
Journal:  Cutis       Date:  2016-05

4.  Nightmares Associated With Vilazodone in a Patient With Major Depressive Disorder.

Authors:  Avinash De Sousa
Journal:  J Clin Psychopharmacol       Date:  2016-12       Impact factor: 3.153

5.  A little "dab" will do ya' in: a case report of neuro-and cardiotoxicity following use of cannabis concentrates.

Authors:  Shannon S Rickner; Dazhe Cao; Kurt Kleinschmidt; Steven Fleming
Journal:  Clin Toxicol (Phila)       Date:  2017-06-23       Impact factor: 4.467

  5 in total
  1 in total

Review 1.  Dabigatran must be used carefully: literature review and recommendations for management of adverse events.

Authors:  Shan Lin; Yan Wang; Lei Zhang; Wei Guan
Journal:  Drug Des Devel Ther       Date:  2019-05-06       Impact factor: 4.162

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.